Free for academic non-profit institutions. Other users need a Commercial license
This gene encodes an integral membrane protein which belongs to one of seven subfamilies of inward-rectifier potassium channel proteins called potassium channel subfamily J. The encoded protein is a subunit of the potassium channel which is homotetrameric. It is controlled by G-proteins and has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Naturally occurring mutations in this gene are associated with aldosterone-producing adenomas. [provided by RefSeq, Aug 2017]
KCNJ5 (Potassium Inwardly Rectifying Channel Subfamily J Member 5) is a Protein Coding gene. Diseases associated with KCNJ5 include Hyperaldosteronism, Familial, Type Iii and Long Qt Syndrome 13. Among its related pathways are Antiarrhythmic Pathway, Pharmacodynamics and Dopamine-DARPP32 Feedback onto cAMP Pathway. Gene Ontology (GO) annotations related to this gene include inward rectifier potassium channel activity and G-protein activated inward rectifier potassium channel activity. An important paralog of this gene is KCNJ6.
The inward-rectifier potassium channel family (also known as 2-TM channels) include the strong inward-rectifier channels (Kir2.x), the G-protein-activated inward-rectifier channels (Kir3.x) and the ATP-sensitive channels (Kir6.x), which combine with sulphonylurea receptors.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005242 | contributes_to inward rectifier potassium channel activity | IDA | 12297500 |
GO:0005244 | voltage-gated ion channel activity | IEA | -- |
GO:0005515 | protein binding | IPI | 12297500 |
GO:0015467 | G-protein activated inward rectifier potassium channel activity | TAS | 8834003 |
GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization | IMP | 20560207 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005886 | plasma membrane | TAS | -- |
GO:0008076 | voltage-gated potassium channel complex | IDA | 20560207 |
GO:0009897 | external side of plasma membrane | IEA | -- |
GO:0016020 | membrane | IEA | -- |
GO:0016021 | integral component of membrane | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Inwardly rectifying K+ channels | ||
2 | GABA receptor activation | ||
3 | Transmission across Chemical Synapses |
.62
|
|
4 | Circadian entrainment | ||
5 | GABAergic synapse |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006811 | ion transport | IEA | -- |
GO:0006813 | potassium ion transport | TAS | 8834003 |
GO:0034220 | ion transmembrane transport | IEA | -- |
GO:0034765 | regulation of ion transmembrane transport | IBA | 21873635 |
GO:0071805 | potassium ion transmembrane transport | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Minoxidil | Approved, Investigational | Pharma | Kir6 channel (KATP) opener | 50 | ||
Nicorandil | Approved, Investigational | Pharma | Potassium channel activator, Kir6 (KATP) channel opener and NO donor | 27 | ||
Glyburide | Approved | Pharma | Kir6 (KATP) channel blocker | 126 | ||
Ethanol | Approved | Pharma | Target | 3481 | ||
Glipizide | Approved, Investigational | Pharma | 42 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs |
---|
Compound | Action | Cas Number |
---|---|---|
Glibenclamide | Kir6 (KATP) channel blocker | 10238-21-8 |
Minoxidil | Kir6 channel (KATP) opener | 38304-91-5 |
Nicorandil | Kir6 (KATP) channel opener and NO donor | 65141-46-0 |
P1075 | Potent Kir6 (KATP) channel opener | 60559-98-0 |
ZM 226600 | Kir6 (KATP) channel opener | 147695-92-9 |
Compound | Action | Cas Number |
---|---|---|
(-)-[3R,4S]-Chromanol 293B | 163163-24-4 | |
1-EBIO | 10045-45-1 | |
4-Aminopyridine | potassium channel-blocking agent | 504-24-5 |
Agitoxin 2 | 168147-41-9 | |
AM 92016 hydrochloride | Potassium channel blocker | 133229-11-5 |
Amiodarone HCl | Anti-arrhythmic drug | 19774-82-4 |
Apamin | 24345-16-2 | |
Azimilide | 149908-53-2 | |
BDS I | ||
Charybdotoxin | 95751-30-7 | |
Chromanol 293B | 163163-23-3 | |
CP 339818 hydrochloride | 478341-55-8 | |
Cromakalim | 94470-67-4 | |
CyPPA | 73029-73-9 | |
Dofetilide | 115256-11-6 | |
DPO-1 | 43077-30-1 | |
Dronedarone | 141626-36-0 | |
Dronedarone HCl | Antiarrhythmic drugs | 141625-93-6 |
E-4031 dihydrochloride | 113559-13-0 | |
Gliclazide | 21187-98-4 | |
Glipizide | 29094-61-9 | |
GW 542573X | 660846-41-3 | |
Hydralazine HCl | 304-20-1 | |
Iberiotoxin | 129203-60-7 | |
ICA 069673 | 582323-16-8 | |
Indapamide | 26807-65-8 | |
L-364,373 | 103342-82-1 | |
Levcromakalim | 94535-50-9 | |
Linopirdine dihydrochloride | 113168-57-3 | |
Margatoxin | 145808-47-5 | |
MaxiPost | 187523-35-9 | |
Minoxidil | 38304-91-5 | |
Mitiglinide Calcium | 145525-41-3 | |
ML 213 | 489402-47-3 | |
ML 277 | 1401242-74-7 | |
ML133 HCl | Potassium channel inhibitor for Kir2.1 | 1222781-70-5 |
Nateglinide | Insulin secretagog agent | 105816-04-4 |
Nicorandil | Potassium channel activator | 65141-46-0 |
Nonactin | 6833-84-7 | |
NS 11021 | 956014-19-0 | |
NS 1619 | 153587-01-0 | |
NS 1643 | 448895-37-2 | |
NS 3623 | 343630-41-1 | |
NS 5806 | 426834-69-7 | |
NS309 | 18711-16-5 | |
P1075 | 60559-98-0 | |
PNU 37883 hydrochloride | 57568-80-6 | |
Repaglinide | Kir6 (KATP) channel blocker | 135062-02-1 |
Retigabine | Activator of voltage-gated potassium channel, an anticonvulsant agent | 150812-12-7 |
RuBi-4AP | 851956-02-0 | |
ShK-Dap22 | 220384-25-8 | |
SKA 31 | 40172-65-4 | |
Tertiapin LQ | ||
Tertiapin-Q | 252198-49-5 | |
Tetraethylammonium chloride | K+ channel blocker | 56-34-8 |
Tolbutamide | CAMP inhibitor | 64-77-7 |
Tolbutamide Sodium | 473-41-6 | |
TRAM-34 | KCa3.1 blocker,potent and highly selective | 289905-88-0 |
UCL 1684 | 199934-16-2 | |
UK 78282 hydrochloride | 136647-02-4 | |
Valinomycin | potassium-specific transporter | 2001-95-8 |
VU 591 hydrochloride | 1315380-70-1 | |
Y-26763 | 127408-31-5 | |
YS-035 hydrochloride | 89805-39-0 | |
ZM 226600 | 147695-92-9 |
ExUns: | 1 | ^ | 2a | · | 2b | ^ | 3 | ^ | 4a | · | 4b | · | 4c | ^ | 5a | · | 5b |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | ||||||||||||||||
SP2: | - | - | - | ||||||||||||||
SP3: | - | - | |||||||||||||||
SP4: |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | KCNJ5 30 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | KCNJ5 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | KCNJ5 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | KCNJ5 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | KCNJ5 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Kcnj5 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Kcnj5 30 |
|
||
Chicken (Gallus gallus) |
Aves | KCNJ5 30 31 |
|
OneToOne | |
Lizard (Anolis carolinensis) |
Reptilia | KCNJ5 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | kcnj5 30 |
|
||
Str.3898 30 |
|
||||
African clawed frog (Xenopus laevis) |
Amphibia | kcnj5-A 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | kcnj5 30 31 |
|
OneToOne | |
Fruit Fly (Drosophila melanogaster) |
Insecta | Ir 32 |
|
|
|
Irk2 32 |
|
|
|||
Worm (Caenorhabditis elegans) |
Secernentea | irk-1 32 |
|
|
|
irk-2 32 |
|
|
|||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToMany |
SNP ID | Clinical significance and condition | Chr 11 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
647708 | Uncertain Significance: Long QT syndrome | 128,911,444(+) |
TG/CA NM_000890.5(KCNJ5):c.171_172inv (p.Gly58Ser) |
MISSENSE | |
836272 | Uncertain Significance: Long QT syndrome | 128,911,998(+) |
G/A NM_000890.5(KCNJ5):c.725G>A (p.Arg242Gln) |
MISSENSE | |
843194 | Uncertain Significance: Long QT syndrome | 128,916,691(+) |
A/G NM_000890.5(KCNJ5):c.1220A>G (p.Lys407Arg) |
MISSENSE | |
848336 | Uncertain Significance: Long QT syndrome | 128,911,936(+) |
G/A NM_000890.5(KCNJ5):c.663G>A (p.Val221=) |
SYNONYMOUS | |
854094 | Uncertain Significance: Long QT syndrome | 128,911,960(+) |
C/G NM_000890.5(KCNJ5):c.687C>G (p.Ile229Met) |
MISSENSE |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
esv2656616 | CNV | deletion | 23128226 |
esv2657032 | CNV | deletion | 23128226 |
esv2745242 | CNV | deletion | 23290073 |
esv2745243 | CNV | deletion | 23290073 |
esv3628051 | CNV | loss | 21293372 |
nsv468892 | CNV | loss | 19166990 |
nsv556563 | CNV | loss | 21841781 |
Disorder | Aliases | PubMed IDs |
---|---|---|
hyperaldosteronism, familial, type iii |
|
|
long qt syndrome 13 |
|
|
andersen cardiodysrhythmic periodic paralysis |
|
|
long qt syndrome |
|
|
long qt syndrome 1 |
|